Newer treatment options that are focused on cardiorenal benefits, weight management, and glycemic control include 4 Sodium-glucose cotransporter 2 (SGLT-2) inhibitors: canagliflozin (Invokana), bexagliflozin (Brenzavvy), dapagliflozin (Farxiga), empagliflozin (Jardiance), and ertugliflozin (Steglatro) GLP-1-RAs: dulaglutide (Trulicity), exenatide ER (Bydureon), exenatide IR (Byetta), liraglutide (Victoza), lixisenatide (Adlyxin), and semaglutide (Ozempic) GIP/GLP-1 RA (tirzepatide [Mounjaro]) The diabetes management landscape is changing
The goal is sustainable lifestyle changes
Epithalon does not appear to affect telomerase in transformed (cancer) cells, which already express constitutive telomerase activity, though this observation requires further investigation
L-carnitine is naturally occurring compound that acts like your body's personal delivery service, transporting fatty acids into your cells' powerhouses, called mitochondria, where they get converted into energy
The weight loss is odd
Hims announced it would sell a starter dose for $49 per month, compared with Novos $149 cash-pay price